Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (141-150 of 525) with videos related to

Pageof 53
Sort By:
Cancer Biology & Therapy|April 21, 2010
Effects of vatalanib on tumor growth can be potentiated by mTOR blockade in vivoAgnes Jaeger-Lansky, Daniel Cejka, Liu Ying, et al.
American Journal of Cancer Research|February 12, 2021
Degradation of BRD4 - a promising treatment approach not only for hematologic but also for solid cancerKarin Bauer, Anna S Berghoff, Matthias Preusser, et al.
Journal of Neurosurgery|November 11, 2008
Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progressionGeorg Widhalm, Stefan Wolfsberger, Matthias Preusser, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2024
Kidney function assessment for eligibility in clinical cancer trials - Data from the European Organisation for Research and Treatment of CancerHannah C Puhr, Eleni Xenophontos, Anne Giraut, et al.
Wiener Klinische Wochenschrift|March 11, 2026
Evolving landscape of glioblastoma research : A 75-year bibliometric study on survival, treatment and gender in authorshipJana Breu, Bernhard Baumann, Jason K Sa, et al.
Cancer|January 22, 2009
O(6)-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas: are progressive tumors potential candidates for temozolomide treatment?Georg Widhalm, Stefan Wolfsberger, Matthias Preusser, et al.
Acta Neuropathologica|April 22, 2005
No prognostic impact of survivin expression in glioblastomaMatthias Preusser, Ellen Gelpi, Radek Matej, et al.
Pharmaceutics|March 26, 2022
Absorption of Direct Oral Anticoagulants in Cancer Patients after GastrectomyHannah C Puhr, Aysegül Ilhan-Mutlu, Matthias Preusser, et al.
Journal of Neuro-Oncology|September 19, 2009
Neurocognitive training in patients with high-grade glioma: a pilot studyMarco Ronald Hassler, Katarzyna Elandt, Matthias Preusser, et al.
Thrombosis Research|October 23, 2012
Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patientsJohannes Thaler, Matthias Preusser, Cihan Ay, et al.
Pageof 53

Showing results (141-150 of 525) with videos related to

Sort By:
Pageof 53
Cancer Biology & Therapy|April 21, 2010
Effects of vatalanib on tumor growth can be potentiated by mTOR blockade in vivoAgnes Jaeger-Lansky, Daniel Cejka, Liu Ying, et al.
American Journal of Cancer Research|February 12, 2021
Degradation of BRD4 - a promising treatment approach not only for hematologic but also for solid cancerKarin Bauer, Anna S Berghoff, Matthias Preusser, et al.
Journal of Neurosurgery|November 11, 2008
Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progressionGeorg Widhalm, Stefan Wolfsberger, Matthias Preusser, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2024
Kidney function assessment for eligibility in clinical cancer trials - Data from the European Organisation for Research and Treatment of CancerHannah C Puhr, Eleni Xenophontos, Anne Giraut, et al.
Wiener Klinische Wochenschrift|March 11, 2026
Evolving landscape of glioblastoma research : A 75-year bibliometric study on survival, treatment and gender in authorshipJana Breu, Bernhard Baumann, Jason K Sa, et al.
Cancer|January 22, 2009
O(6)-methylguanine DNA methyltransferase immunoexpression in nonfunctioning pituitary adenomas: are progressive tumors potential candidates for temozolomide treatment?Georg Widhalm, Stefan Wolfsberger, Matthias Preusser, et al.
Acta Neuropathologica|April 22, 2005
No prognostic impact of survivin expression in glioblastomaMatthias Preusser, Ellen Gelpi, Radek Matej, et al.
Pharmaceutics|March 26, 2022
Absorption of Direct Oral Anticoagulants in Cancer Patients after GastrectomyHannah C Puhr, Aysegül Ilhan-Mutlu, Matthias Preusser, et al.
Journal of Neuro-Oncology|September 19, 2009
Neurocognitive training in patients with high-grade glioma: a pilot studyMarco Ronald Hassler, Katarzyna Elandt, Matthias Preusser, et al.
Thrombosis Research|October 23, 2012
Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patientsJohannes Thaler, Matthias Preusser, Cihan Ay, et al.
Pageof 53